FIGURE 1.

Inhibition (%) of SARS‐CoV‐2 binding to the human host receptor angiotensin converting enzyme‐2 after vaccination with the BNT162b2 mRNA vaccine (Pfizer) and the AZD1222 vaccine (AstraZeneca, AZ). NAbs were measured on day 1 (vaccination date), day 22, and day 50. Asterisks indicate statistically significant differences between the compared groups: *p‐value = 0.031, **p‐value <0.001. The boxplot borders refer to the quartiles of the distribution, while the overlaid dots represent the individual values of NAbs inhibition